Abstract
Background: Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) is a safe and well-tolerated treatment for patients with peritoneal metastases (PM). Our aim was to report oncological outcomes after PIPAC for colorectal PM.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
